An MRSA superbug jab in the works

Now from the makers of the deadly cervical cancer vaccine: An MRSA superbug jab in the works

(NaturalNews) The woman responsible for developing the infamous Gardasil vaccine for cervical cancer, which has seriously maimed or killed tens of thousands of young girls since first being introduced, is working on a new vaccine for antibiotic-resistant methicillin-resistant Staphylococcus aureus (MRSA), according to new reports. And while the first vaccine for MRSA will likely not hit the market for at least another decade, the race is on to make it available as quickly as possible, an endeavor that has many questioning how this new jab will influence public health.

The last few times that experimental vaccines for MRSA were tested in humans, the results were disastrous. Back in 2011, for instance, a Merck & Co. trial involving an experimental vaccine for MRSA led to such high rates of multi-organ dysfunction and death that the drug giant flat-out cancelled the trial, declaring that the vaccine, known as V710, was "unlikely to show a significant clinical benefit." At a later meeting of IDWeek 2012, representatives of the vaccine were forced to admit publicly that it had been a complete failure, despite the fact that it produced what they claim was a "robust immunologic response."

Previous attempts at developing a vaccine for MRSA have similarly failed miserably, but none of this has stopped Kathrin Jansen from moving forward with her own novel take on a MRSA vaccine. According to reports, Jansen's new vaccine targets MRSA from four different angles, which she hopes will prove to be more effective than earlier approaches that targeted the superbug from only one or two angles at most. And she is apparently anxious to begin larger human clinical trials as soon as possible, as competitors like GlaxoSmithKline and Novartis are also working on introducing their own MRSA vaccines in the next few years.

As a note, Jansen previously developed and brought to market the deadly HPV vaccine Gardasil for drug giant Merck. She also helped develop the $4 billion-a-year multivalent pneumonia and meningitis vaccine Prevnar 13 for Pfizer, which has been linked not only to high rates of neurological damage in infants, but also to a higher rate of infection among those vaccinated compared to those unvaccinated. In other words, Jansen's track record of vaccine safety is utterly dismal, and yet she is busy trying to push her new MRSA vaccine through the clinical trial system.

"If Pfizer gets the results they hope for, likely later this year, the company expects to meet with regulators to iron out a plan for larger trials involving thousands of individuals," explains a recent Fox News report.

Pharmaceutical drugs are the problem, not the solution
But the irony in all this is that MRSA emerged as a deadly disease as a direct result of pharmaceutical drugs, for which people like Jansen are trying to create more drugs as a solution. Staph, as some readers may already be aware, has lived on human skin and in human bodies for centuries. It was not until the advent of synthetic antibiotics and other drugs that the bacteria became deadly. And now, rather than try to eliminate the causes of MRSA and other superbugs, conventional scientists want to create even more drugs to supposedly treat them.

Not only this, but many scientists are also questioning the validity of trying to develop a vaccine for an infection that humans, in all honesty, still know very little about. One prominent expert, as quoted by Fox News, says current efforts to develop an effective MRSA vaccine "predate an adequate understanding of the human response to infection."

source:-
http://www.naturalnews.com/040975_MRSA_vaccine_deadly_vaccines_Pfizer.html